PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Hösel, M.* ; Quasdorff, M.* ; Ringelhan, M. ; Kashkar, H.* ; Debey-Pascher, S.* ; Sprinzl, M.F. ; Bockmann, J.H. ; Arzberger, S. ; Webb, D.* ; von Olshausen, G.* ; Weber, A.* ; Schultze, J.L.* ; Büning, H.* ; Heikenwälder, M. ; Protzer, U.

Hepatitis B virus activates signal transducer and activator of transcription 3 supporting hepatocyte survival and virus replication.

Cell. Mol. Gast. Hept. 4, 339-363 (2017)
Verlagsversion Postprint DOI
Open Access Gold
Creative Commons Lizenzvertrag
Background & Aims The human hepatitis B virus (HBV) is a major cause of chronic hepatitis and hepatocellular carcinoma (HCC), but molecular mechanisms driving liver disease and carcinogenesis are largely unknown. We therefore studied cellular pathways altered by HBV infection. Methods We performed gene expression profiling of primary human hepatocytes (PHH) infected with HBV and proved the results in HBV-replicating cell lines and human liver tissue using real time PCR and Western blotting. Activation of signal transducer and activator of transcription (STAT3) was examined in HBV-replicating human hepatocytes, HBV-replicating mice and liver tissue from HBV-infected individuals using Western blotting, STAT3-luciferase reporter assay, and immunohistochemistry. The consequences of STAT3 activation on HBV infection and cell survival were studied by chemical inhibition of STAT3 phosphorylation and siRNA-mediated knockdown of STAT3. Results Gene expression profiling of HBV-infected PHH detected no interferon response, while genes encoding for acute phase and anti-apoptotic proteins were up-regulated. This gene regulation was confirmed in liver tissue samples of patients with chronic HBV infection and in HBV-related HCC. Pathway analysis revealed activation of STAT3 to be the major regulator. Interleukin-6-dependent and -independent activation of STAT3 was detected in HBV-replicating hepatocytes in cell culture and in vivo. Prevention of STAT3 activation by inhibition of Janus tyrosine kinases as well as siRNA-mediated knockdown of STAT3 induced apoptosis and reduced HBV replication and gene expression. Conclusions HBV activates STAT3 signaling in hepatocytes to foster its own replication but also to prevent apoptosis of infected cells. This very likely supports HBV-related carcinogenesis.  
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
0.000
0.771
14
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter hepatitis B virus infection, STAT3 signaling, hepatocellular carcinoma, apoptosis
Sprache englisch
Veröffentlichungsjahr 2017
HGF-Berichtsjahr 2017
ISSN (print) / ISBN 2352-345X
e-ISSN 2352-345X
Zeitschrift Cellular and Molecular Gastroenterology and Hepatology
Quellenangaben Band: 4, Heft: 3, Seiten: 339-363 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort New York, NY
Institut(e) Institute of Virology (VIRO)
POF Topic(s) 30203 - Molecular Targets and Therapies
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-502700-003
G-551600-001
DOI 10.1016/j.jcmgh.2017.07.003
Scopus ID 85031827346
Erfassungsdatum 2017-07-24
[➜Korrektur melden]